{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T19:09:50Z","timestamp":1777748990583,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.urolonc.2024.01.012","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T13:22:09Z","timestamp":1705929729000},"page":"161.e9-161.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The association between frailty, hypogonadism, and postoperative outcomes among men undergoing radical cystectomy"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5050-7414","authenticated-orcid":false,"given":"Daniel R.","family":"Greenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hriday P.","family":"Bhambhvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis C.","family":"Gago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward M.","family":"Schaeffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua J.","family":"Meeks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Brannigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan E.","family":"Shoag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua A.","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.01.012_bib0001","unstructured":"Anon: Cancer Stat Facts: Bladder Cancer. National Cancer Institute; 2023. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/urinb.html, accessed July 24, 2023."},{"key":"10.1016\/j.urolonc.2024.01.012_bib0002","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","article-title":"Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis","volume":"24","author":"Zlotta","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0003","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2017.04.086","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/ASTRO\/SUO guideline","volume":"198","author":"Chang","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0004","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2147\/CMAR.S161566","article-title":"Cystectomy for bladder cancer in elderly patients is not associated with increased 30- and 90-day mortality or readmission, length of stay, and cost: propensity score matching using a population database","volume":"10","author":"Lin","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/BLC-160061","article-title":"Readmission rate and causes at 90-day after radical cystectomy in patients on early recovery after surgery protocol","volume":"3","author":"Altobelli","year":"2017","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0006","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/JU.0000000000001387","article-title":"Timing, patterns and predictors of 90-day readmission rate after robotic radical cystectomy","volume":"205","author":"Cacciamani","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0007","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.2147\/CMAR.S199432","article-title":"Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion","volume":"11","author":"Lee","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0008","doi-asserted-by":"crossref","first-page":"659.e13","DOI":"10.1016\/j.urolonc.2017.07.013","article-title":"Temporal trends in perioperative morbidity for radical cystectomy using the National Surgical Quality Improvement Program database","volume":"35","author":"Johnson","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0009","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/S0140-6736(18)30996-6","article-title":"Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial","volume":"391","author":"Parekh","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000362421","article-title":"The Charlson Comorbidity Index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladder","volume":"93","author":"Mayr","year":"2014","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0011","doi-asserted-by":"crossref","first-page":"256.e1","DOI":"10.1016\/j.urolonc.2015.12.010","article-title":"Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy","volume":"34","author":"Chappidi","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0012","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.urolonc.2018.10.002","article-title":"Frailty as a predictor of complications after radical cystectomy: a prospective study of various preoperative assessments","volume":"37","author":"Burg","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0013","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/bju.15132","article-title":"Preoperative frailty and outcome in patients undergoing radical cystectomy","volume":"126","author":"van der Vlies","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0014","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11934-017-0701-z","article-title":"The Preoperative assessment and optimization of patients undergoing major urological surgery","volume":"18","author":"Cui","year":"2017","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0015","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.urolonc.2020.02.019","article-title":"Nutrition risk and assessment process in patients with bladder cancer undergoing radical cystectomy","volume":"38","author":"Michel","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0016","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jso.27114","article-title":"Association between frailty and low testosterone among men undergoing oncologic surgery","volume":"127","author":"Hudnall","year":"2023","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0017","article-title":"Association between patient frailty and postoperative mortality across multiple noncardiac surgical specialties","volume":"156","author":"George","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0018","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.euros.2021.05.008","article-title":"Serum total testosterone and premature mortality among men in the USA","volume":"29","author":"Fantus","year":"2021","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0019","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.juro.2015.10.175","article-title":"Root causes and modifiability of 30-day hospital readmissions after radical cystectomy for bladder cancer","volume":"195","author":"James","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0020","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.juro.2018.03.115","article-title":"Evaluation and management of testosterone deficiency: AUA guideline","volume":"200","author":"Mulhall","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0021","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","article-title":"Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study","volume":"391","author":"Gilbert","year":"2018","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0022","doi-asserted-by":"crossref","first-page":"648","DOI":"10.21105\/joss.00648","article-title":"comorbidity: An R package for computing comorbidity scores","volume":"3","author":"Gasparini","year":"2018","journal-title":"JOSS"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0023","unstructured":"Therneau TM: A Package for Survival Analysis in R. R package version 3.5-7.; 2023. Available at: https:\/\/CRAN.R-project.org\/package=survival."},{"key":"10.1016\/j.urolonc.2024.01.012_bib0024","unstructured":"Anon: R: A language and environment for statistical computing. R Core Team; 2023. Available at: https:\/\/www.R-project.org\/."},{"key":"10.1016\/j.urolonc.2024.01.012_bib0025","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.3390\/ijerph20032421","article-title":"Identifying the biomarker profile of pre-frail and frail people: a cross-sectional analysis from UK biobank","volume":"20","author":"Chu","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/507395","article-title":"Testosterone and adipokines are determinants of physical performance, strength, and aerobic fitness in frail, obese, older adults","volume":"2014","author":"Aguirre","year":"2014","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0027","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.sopen.2021.11.002","article-title":"Low free testosterone is associated with increased mortality in frail surgical patients","volume":"7","author":"Lin","year":"2022","journal-title":"Surg Open Sci"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0028","doi-asserted-by":"crossref","first-page":"435.e23","DOI":"10.1016\/j.urolonc.2020.12.013","article-title":"Characterization of perioperative androgen profiles in men with bladder cancer undergoing radical cystectomy","volume":"39","author":"Smelser","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0029","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/13685538.2020.1808968","article-title":"Testosterone status is not associated with bladder cancer parameters in adult male patients: results of a prospective controlled study","volume":"24","author":"Kafkasli","year":"2021","journal-title":"Aging Male"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0030","first-page":"226","article-title":"Should family physicians screen for testosterone deficiency in men? No: screening may be harmful, and benefits are unproven","volume":"91","author":"Fugh-Berman","year":"2015","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0031","doi-asserted-by":"crossref","DOI":"10.1177\/2325967117722794","article-title":"Perioperative testosterone supplementation increases lean mass in healthy men undergoing anterior cruciate ligament reconstruction: a randomized controlled trial","volume":"5","author":"Wu","year":"2017","journal-title":"Orthop J Sports Med"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0032","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1507\/endocrj.EJ20-0365","article-title":"Patient-reported outcomes and biochemical alterations during hormonal therapy in men with hypogonadotropic hypogonadism who have finished infertility treatment","volume":"68","author":"Shiraishi","year":"2021","journal-title":"Endocr J"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0033","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0034","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1530\/EJE-11-0221","article-title":"Onset of effects of testosterone treatment and time span until maximum effects are achieved","volume":"165","author":"Saad","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0035","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","article-title":"Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore longitudinal study of aging","volume":"86","author":"Harman","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urolonc.2024.01.012_bib0036","doi-asserted-by":"crossref","first-page":"951","DOI":"10.7326\/0003-4819-133-12-200012190-00010","article-title":"Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study","volume":"133","author":"Amin","year":"2000","journal-title":"Ann Intern Med"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924000139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924000139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T22:42:43Z","timestamp":1712875363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924000139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1078143924000139"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.012","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between frailty, hypogonadism, and postoperative outcomes among men undergoing radical cystectomy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}